M&A Deal Summary

Sun Pharma Acquires JSC Biosintez

On November 23, 2016, Sun Pharma acquired life science company JSC Biosintez

Acquisition Highlights
  • This is Sun Pharma’s 7th transaction in the Life Science sector.
  • This is Sun Pharma’s 1st transaction in Russia.

M&A Deal Summary
Date 2016-11-23
Target JSC Biosintez
Sector Life Science
Buyer(s) Sun Pharma
Deal Type Add-on Acquisition

Target

JSC Biosintez

Penza, Russia
JSC Biosintez is a pharmaceutical company engaged in manufacture and marketing of pharmaceutical products.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sun Pharma

Mumbai, India
Category Company
Founded 1983
Sector Life Science
Employees37,000
Revenue 477.6B INR (2024)
DESCRIPTION

Sun Pharma is a specialty generic pharmaceutical company. Products are sold through drug stores, mass merchants, grocery stores, and gift/specialty stores. Sun Pharma was founded in 1983 and is based in Mumbai, India.

DEAL STATS #
Overall 12 of 14
Sector (Life Science) 7 of 9
Type (Add-on Acquisition) 5 of 7
Country (Russia) 1 of 1
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-09-17 InSite Vision

Alameda, California, United States

InSite Vision, Inc. focuses on developing new specialty ophthalmic products, including three late-stage programmes.

Buy $48M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-27 Pola Pharma

Shinagawa, Japan

Pola Pharma, Inc. is a pharmaceutical company to healthier, more beautiful skin. Pola Pharma has two factories in Japan to make topical products and injectables. It has research and development capabilities to develop new technologies and formulations. Pola Pharma, Inc. was founded in 2007 and is based in Shinagawa, Japan.

Buy $1M
Mergr

Product

Company

Legal